NSAID targets SIRT3 to trigger mitochondrial dysfunction and gastric cancer cell death
Subhashis Debsharma(Indian Institute of Chemical Biology), Uday Bandyopadhyay(Bose Institute), Shiladitya Nag(Indian Institute of Chemical Biology), Somnath Mazumder(Indian Institute of Chemical Biology), Zhumur Ghosh(Bose Institute), Debanjan Saha(Indian Institute of Chemical Biology), Troyee Das(Bose Institute), Saikat Pramanik(Indian Institute of Chemical Biology), Nakul C. Maiti(Indian Institute of Chemical Biology), Rudranil De(Unknown), Uttam Pal(Indian Institute of Chemical Biology), Samik Bindu(Cooch Behar Panchanan Barma University), Chinmoy Banerjee(Indian Institute of Chemical Biology)
Cited by 16
Related Papers
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
|Biochemical Pharmacology|2020|1.8k
VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT
|Unknown|2011|297
Indomethacin impairs mitochondrial dynamics by activating the PKCζ–p38–DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells
|Journal of Biological Chemistry|2019|85
Antimalarial Activity of Small-Molecule Benzothiazole Hydrazones
|Antimicrobial Agents and Chemotherapy|2016|79
Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight
|Molecular and Cellular Biochemistry|2022|68